Google+ Facebook Twitter Twitter

Urgent need for early COVID-19 treatments

COVID-19 treatments for people with early infection are needed urgently, according to Anthony S Fauci, Director of the US National Institute of Allergy and Infectious Diseases.

Treating people early in the course of infection with SARS-CoV-2 would speed their recovery, reduce the likelihood that they develop severe outcomes and reduce demand on the healthcare system, Fauci and colleagues wrote in JAMA.

Despite experiencing only mild symptoms early in infection, many COVID-19 patients progress to severe disease that leads to hospitalisation. Some also will experience lengthy recoveries and develop long-lasting fatigue, mental impairment and problems with heart and lung function.

While several treatments, such as remdesivir and dexamethasone, are available, or are in development, that can be administered early during the course of infection to prevent disease progression and longer-term complications, more are urgently needed, they write.

Image Credit: iStock

Related Articles

Biosensors for COVID-19

Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it.

Do antibiotics reach bacteria hiding in tissues?

Scientists have developed a new imaging method to see where antibiotics have reached bacteria within tissues.

Delighting in the negative

Sarah May, Deputy Chief Executive of the IBMS, wonders at our apparent inability to celebrate success.

The vaccine race

With more than 150 COVID-19 vaccines in development, we put the three front-runners under the microscope and look at the incredible, unprecedented development work of the last year.